|
|
 |
Quality
Medical & Forensic |
|
|
|
|
|
|
|
|
 |
          |
 |
|
|
INTENDED USE
A visual one-step five (5) panel immunoassay* for the simultaneous, qualitative detection of multiple drugs and metabolites in human urine using one test device. This all inclusive testing card is used to obtain a rapid, visual, qualitative result indicating drug usage or abuse within a few minutes. This product will not test for quantitative measurements of drug concentrations in the body but will indicate their presence at or above minimum concentrations established by the NIDA and the World Health Organization. The QuickScreen™ Pro Drug testing device is approved by the FDA. This test is recommended as an all inclusive scan when drug use is suspected but the specific target drug is unknown.
The QuickScreen™ Pro
5 Drug Test Card is a lateral flow, one-step panel immunoassay for the qualitative
detection of Amphetamines, benzoylecgonine (cocaine metabolite),
Methamphetamines (including Ecstasy*),
Opiates (morphine/heroin metabolite) and 11-nor-D 9 Tetrahydrocannibinol-9-carboxylic acid
(marijuana) in human urine at the following cut-off concentrations based on the
following Federal
(NIDA) guidelines.
Urine based screening test for drugs of abuse range from simple immunoassay test to complex analytical procedures. The speed and sensitivity of immunoassays have made them the most widely accepted method for screening urine for drugs of abuse. A visual one-step five panel urine test can be administered any time, at any place, and provide a qualitative and definitive "yes or no" answer in three to four (3-4) minutes (8 minutes for THC due to high sensitivity levels) without the costly and time consuming process of clinical analysis. See a short slide presentation and overview of the QuickScreen™ Pro 5.
A brief
slide show
gives a basic
overview on the QuickScreen™
Pro 5.
Drugs and drug metabolites remain at detectable levels in the human body for
various periods of time. Information on typical "time after use" periods at which drug and drug
metabolites can be detected is illustrated in a chart located on the
FAQ page. For information on the chemistry of the test please see the
Technical Properties
page. For information
on usage and result interpretation of the test
go to Test Usage. For
comprehensive background information on drug testing see the
Drug Testing Q&A. A chart summarizing the benefits of drug screening tests can be found at
Usage Benefits For testing suspect urine samples for dilution, adulteration or tampering please
the Adulteration Test page. The QuickScreen™ Pro Drug Test Card is presently available in packs of 1, 3, 6, 12, 25, 50 and 100 test packs. For quantities exceeding 250 units please contact us for special volume pricing. Complete use and background information including laboratory testing results, cross reaction charts, drug characteristics and other useful information is included with each test kit. The QuickScreen™ Pro Drug Test Card is approved by the FDA, method and claims.
*This immunoassay provides a preliminary, first-line analytical test result. A more specific alternative chemical method can be used in order to obtain a confirmed laboratory analytical result. Gas chromatography/mass spectrometry (GCIMS) has been established as the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). For specific situations where laboratory confirmation of positive results is required, please refer to the QuickScreen Pro Drug Test page. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
